Treatment Of Fibrosis

Abstract

This invention is in the field of treatment of fibrosis. In particular, it relates to the treatment of IPF using N-Cadherin antibodies. The antibody may be any antagonising or neutralizing N-Cadherin antibody suitable for therapeutic use.


Claims
Download PDF
Document Preview
Document History
  • Publication: Oct 3, 2013
  • Application: Mar 13, 2013
    WO IB 2013051989 W
  • Priority: Mar 27, 2012
    US US 201261616023 P

Download Citation


Sign in to the Lens

Feedback